Agios Pharmaceuticals, Inc. Liquidation Value
AGIO
Other
Cash & Equivalents
$89.13M
As of 2025-12-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $89.13M
Total Obligations: -$122.41M
$-33.28M
Per share: $-0.57
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $89.13M
AR: $21.15M
Total Obligations: -$122.41M
$-12.13M
Per share: $-0.21
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $89.13M
AR: $21.15M
Inventory: $32.92M
Total Obligations: -$122.41M
$20.79M
Per share: $0.36
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $-33.28M | $-0.57 |
| Liquid Liquidation Value | $-12.13M | $-0.21 |
| Operating Liquidation Value | $20.79M | $0.36 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $89.13M |
| Accounts Receivable | $21.15M |
| Inventory | $32.92M |
| Current Liabilities | $82.21M |
| Long-term Debt | N/A |
| Op. Lease Liability | $40.21M |
| Finance Lease | N/A |
| Shares Outstanding | 58.4M |
Explore all 184 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $89.13M | $21.15M | $32.92M | $18.36M | $82.21M | N/A | $40.21M | N/A |
| 2025-09-30 | $92.71M | $10.06M | $32.03M | $19.55M | $74.76M | N/A | $44.52M | N/A |
| 2025-06-30 | $80.87M | $9.97M | $30.85M | $17.53M | $70.41M | N/A | $48.76M | N/A |
| 2025-03-31 | $78.96M | $6.69M | $29.61M | $13.73M | $52.37M | N/A | $52.94M | N/A |
▼ Community Notes